Literature DB >> 14567084

[Molecular genetics principles in cystic fibrosis. An example of genetic illness in pneumology].

B Tümmler1, M Stuhrmann.   

Abstract

The generalized exocrinopathy cystic fibrosis (CF) is caused by molecular lesions in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The basic defect of this autosomal-recessive disorder manifests in decreased permeability for chloride ions across the apical epithelial membrane. Of the more than 1,000 known CFTR mutations the most frequent mutation F508del occurs on about 70% of North- and Mideuropean CF chromosomes. CFTR mutations are also causatively involved in male infertility, pancreatitis and several airway diseases like disseminated bronchiectasis. The differential diagnosis between CF, other CFTR-opathies and diseases of unrelated etiology can be achieved by the assessment of clinical symptoms, CFTR mutation analysis and electrophysiological bioassays (sweat test, nasal potential difference, intestinal current measurements).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14567084     DOI: 10.1007/s00108-003-0965-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  24 in total

1.  CFTR gene variant IVS8-5T in disseminated bronchiectasis.

Authors:  P F Pignatti; C Bombieri; M Benetazzo; A Casartelli; E Trabetti; L S Gilè; L C Martinati; A L Boner; M Luisetti
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

2.  Recommendations for quality improvement in genetic testing for cystic fibrosis. European Concerted Action on Cystic Fibrosis.

Authors:  E Dequeker; H Cuppens; J Dodge; X Estivill; M Goossens; P F Pignatti; H Scheffer; M Schwartz; M Schwarz; B Tümmler; J J Cassiman
Journal:  Eur J Hum Genet       Date:  2000-09       Impact factor: 4.246

3.  Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings.

Authors:  I Bronsveld; F Mekus; J Bijman; M Ballmann; H R de Jonge; U Laabs; D J Halley; H Ellemunter; G Mastella; S Thomas; H J Veeze; B Tümmler
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

4.  Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis.

Authors:  J Ockenga; M Stuhrmann; M Ballmann; N Teich; V Keim; T Dörk; M P Manns
Journal:  Am J Gastroenterol       Date:  2000-08       Impact factor: 10.864

5.  C-terminal truncations destabilize the cystic fibrosis transmembrane conductance regulator without impairing its biogenesis. A novel class of mutation.

Authors:  M Haardt; M Benharouga; D Lechardeur; N Kartner; G L Lukacs
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

Review 6.  Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.

Authors:  M M Reddy; P M Quinton
Journal:  JOP       Date:  2001-07

Review 7.  Cystic fibrosis: genotypic and phenotypic variations.

Authors:  J Zielenski; L C Tsui
Journal:  Annu Rev Genet       Date:  1995       Impact factor: 16.830

8.  Genetic determination of exocrine pancreatic function in cystic fibrosis.

Authors:  P Kristidis; D Bozon; M Corey; D Markiewicz; J Rommens; L C Tsui; P Durie
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

9.  Cystic-fibrosis-like disease unrelated to the cystic fibrosis transmembrane conductance regulator.

Authors:  F Mekus; M Ballmann; I Bronsveld; T Dörk; J Bijman; B Tümmler; H J Veeze
Journal:  Hum Genet       Date:  1998-05       Impact factor: 4.132

10.  Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens.

Authors:  M Chillón; T Casals; B Mercier; L Bassas; W Lissens; S Silber; M C Romey; J Ruiz-Romero; C Verlingue; M Claustres
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.